| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 三叶橡胶黄酮; Heveaflavone | CFN98236 | 23132-13-0 | C33H24O10 = 580.6 | 5mg | QQ客服：215959384 |
| 5,7-二羟基-8-甲氧基黄酮二乙酸酯; 5,7-Diacetoxy-8-methoxyflavone | CFN98240 | 23246-80-2 | C20H16O7 = 368.3 | 5mg | QQ客服：3257982914 |
| 竹柏双黄酮B; Putraflavone | CFN98246 | 23624-21-7 | C32H22O10 = 566.5 | 5mg | QQ客服：1457312923 |
| (-)-表阿夫儿茶精; (-)-Epiafzelechin | CFN98271 | 24808-04-6 | C15H14O5 = 274.3 | 10mg | QQ客服：2159513211 |
| 阿夫儿茶精; (+)-Afzelechin | CFN98280 | 2545-00-8 | C15H14O5 = 274.3 | 5mg | QQ客服：3257982914 |
| 毡毛美洲茶素; Velutin | CFN98290 | 25739-41-7 | C17H14O6 = 314.3 | 5mg | QQ客服：1413575084 |
| 3-(4-羟基苯亚甲基)-5-羟基-7-甲氧基色满-4-酮; 5-Hydroxy-7-methoxy-3-(4-hydroxybenzylidene)chroman-4-one | CFN98291 | 259653-54-8 | C17H14O5 = 298.3 | 5mg | QQ客服：2159513211 |
| 荭草苷; Orientin | CFN98136 | 28608-75-5 | C21H20O11 = 448.38 | 20mg | QQ客服：2159513211 |
| 异荭草苷; 异荭草素; Luteolin-6-C-glucoside | CFN98137 | 4261-42-1 | C21H20O11 = 448.38 | 20mg | QQ客服：1457312923 |
| 地奥司明; Diosmin | CFN98145 | 520-27-4 | C28H32O15 = 608.54 | 20mg | QQ客服：2056216494 |
| 香蒲新苷; Typhaneoside | CFN98146 | 104472-68-6 | C34H42O20 = 770.69 | 20mg | QQ客服：2056216494 |
| 蛇葡萄素； 二氢杨梅素; Ampelopsin | CFN98326 | 27200-12-0 | C15H12O8 = 320.3 | 20mg | QQ客服：1413575084 |
| 堪非醇3-O-桑布双糖苷; Leucoside | CFN98333 | 27661-51-4 | C26H28O15 = 580.5 | 10mg | QQ客服：1413575084 |
| 5-O-beta-D-吡喃葡萄糖苷芹菜甙元; Apigenin 5-O-beta-D-glucopyranoside | CFN98352 | 28757-27-9 | C21H20O10 = 432.4 | 10mg | QQ客服：2159513211 |
| 羟基甲基氧丙基苯并吡喃酮; Cassiachromone | CFN98359 | 28955-30-8 | C13H12O4 = 232.2 | 5mg | QQ客服：1413575084 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)